{"id":144613,"date":"2025-02-20T12:06:25","date_gmt":"2025-02-20T11:06:25","guid":{"rendered":"https:\/\/www.startupbusiness.it\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/"},"modified":"2025-02-20T12:09:36","modified_gmt":"2025-02-20T11:09:36","slug":"first-closing-at-eur-7-3-mln-for-approximas-series-a","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/","title":{"rendered":"First closing at EUR 7.3 mln for Approxima’s Series A"},"content":{"rendered":"\n

Approxima reports that it has completed the first closing of a EUR 7.3 million Series A financing round. The round is led by ENEA Tech and Biomedical and Panak\u00e8s Partners, with continued support from existing shareholders Club degli Investitori and other business angels. <\/strong> The round remains open for subscription by other co-investors in the coming months. In connection with the financing, Chiara Vieceli, an international cardiovascular expert, joined the Board of Directors and a further expansion of the Board is in progress. <\/p>\n\n

“I am deeply honoured and grateful to have been appointed to the Board of Directors. It is truly exciting to be part of a team dedicated to transforming the lives of patients with tricuspid valve regurgitation through innovative therapies. Together, we are pioneering a solution that has the potential to restore physiological function to the tricuspid valve and have a profound impact on patient outcomes. I look forward to contributing to Approxima’s success and vision as we work towards this transformative goal,’ Vieceli comments in a note. <\/strong><\/p>\n\n

The funds raised from the new funding will be used to further advance the technology through conclusive pre-clinical testing and pilot clinical trials.<\/p>\n\n

Approxima is a medtech start-up that is developing a percutaneous right ventricular remodelling technology for the treatment of patients with tricuspid regurgitation (TR). This technology has been developed to offer a transformative approach to treating TR patients by addressing its underlying cause, ventricular dilatation, and thereby restoring tricuspid valve function with a simple and efficient percutaneous implantation procedure. Its impact extends beyond the valve itself, while also improving right ventricular performance and maintaining all possible salvage options, including repair or replacement of the native valve. <\/p>\n\n

“Over the past two years, our team has achieved important technological breakthroughs and provided solid pre-clinical evidence. We are thrilled to have closed this important funding round, backed by the continued support of our existing shareholders and a new investor who shares our vision. This milestone allows us to take the next significant step, which is the execution of pilot clinical studies,’ says Michal Jaworek, CEO and co-founder of Approxima<\/strong><\/p>\n\n

“There is an urgent need for new therapeutic solutions to address the growing clinical need posed by tricuspid valve regurgitation. With Approxima we are developing an innovative technology that promises to fill this critical gap and improve patient outcomes. The funding obtained will play a key role in accelerating patient access to this therapy,’ adds Paolo Denti, CMO of Approxima.<\/strong> <\/p>\n\n

‘We have supported the company since its inception and continue to do so because we truly believe in this new and well-differentiated approach to offer a flexible treatment option to both doctors and patients,’ says Barbara Castellano, partner at Panak\u00e8s Partners.<\/strong><\/p>\n\n

“This investment represents a significant step forward in precision medicine innovation. Approxima has developed a unique solution for the treatment of tricuspid insufficiency, a complex condition for which current treatment options have significant limitations. Our support for this innovative technology reinforces our commitment to promoting advanced, personalised solutions that not only improve patients’ quality of life, but also strengthen the national healthcare system by supporting the development of cutting-edge medical devices. This investment is a concrete demonstration of how the synergy between research, technology and capital can generate a positive and lasting impact on the country’s healthcare system,’ emphasises Maria Cristina Porta, Director General of ENEA Tech and Biomedical.<\/strong><\/p>\n\n

“The funding obtained will accelerate patient access to Approxima’s unique and transformative solution, which directly addresses the root cause of the disease. This technology is strategically positioned among the emerging treatments for tricuspid and is a perfect fit for the portfolios of the leading players in the structural heart industry,” says Umberto Pasquali, Chairman of the Board of Directors. <\/strong>(photo by spiros koufos <\/a>on Unsplash<\/a>)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels<\/p>\n","protected":false},"author":125,"featured_media":144611,"comment_status":"closed","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1317],"tags":[2500],"companies":[1615],"journalist":[],"class_list":["post-144613","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-approxima-en","companies-leaks-of-the-week-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","width":150,"height":113,"crop":false,"srcset":false,"alt":"salute cuore"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","width":1024,"height":768,"crop":false,"srcset":false,"alt":"salute cuore"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","width":1280,"height":960,"crop":false,"srcset":false,"alt":"salute cuore"}},"acf":[],"yoast_head":"\nFirst closing at EUR 7.3 mln for Approxima's Series A<\/title>\n<meta name=\"description\" content=\"The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First closing at EUR 7.3 mln for Approxima's Series A\" \/>\n<meta property=\"og:description\" content=\"The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T11:06:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-20T11:09:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"First closing at EUR 7.3 mln for Approxima’s Series A\",\"datePublished\":\"2025-02-20T11:06:25+00:00\",\"dateModified\":\"2025-02-20T11:09:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/\"},\"wordCount\":636,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/spiros-koufos-H0fBJtsaz-o-unsplash.webp\",\"keywords\":[\"Approxima\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/\",\"name\":\"First closing at EUR 7.3 mln for Approxima's Series A\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/spiros-koufos-H0fBJtsaz-o-unsplash.webp\",\"datePublished\":\"2025-02-20T11:06:25+00:00\",\"dateModified\":\"2025-02-20T11:09:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-closing-at-eur-7-3-mln-for-approximas-series-a\\\/144613\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/spiros-koufos-H0fBJtsaz-o-unsplash.webp\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/spiros-koufos-H0fBJtsaz-o-unsplash.webp\",\"width\":1280,\"height\":960,\"caption\":\"salute cuore\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First closing at EUR 7.3 mln for Approxima's Series A","description":"The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/","og_locale":"en_US","og_type":"article","og_title":"First closing at EUR 7.3 mln for Approxima's Series A","og_description":"The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels","og_url":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/","og_site_name":"Startupbusiness.it","article_published_time":"2025-02-20T11:06:25+00:00","article_modified_time":"2025-02-20T11:09:36+00:00","og_image":[{"width":1280,"height":960,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","type":"image\/webp"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"First closing at EUR 7.3 mln for Approxima’s Series A","datePublished":"2025-02-20T11:06:25+00:00","dateModified":"2025-02-20T11:09:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/"},"wordCount":636,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","keywords":["Approxima"],"articleSection":["Funding News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/","url":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/","name":"First closing at EUR 7.3 mln for Approxima's Series A","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","datePublished":"2025-02-20T11:06:25+00:00","dateModified":"2025-02-20T11:09:36+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"The medtech startup is backed by ENEA Tech and biomedical, Panak\u00e8s Partners, Club degli Investitori and other business angels","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/first-closing-at-eur-7-3-mln-for-approximas-series-a\/144613\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2025\/02\/spiros-koufos-H0fBJtsaz-o-unsplash.webp","width":1280,"height":960,"caption":"salute cuore"},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=144613"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144613\/revisions"}],"predecessor-version":[{"id":144614,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/144613\/revisions\/144614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/144611"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=144613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=144613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=144613"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=144613"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=144613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}